Filing Details
- Accession Number:
- 0001209191-20-027696
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-07 16:29:03
- Reporting Period:
- 2020-05-05
- Accepted Time:
- 2020-05-07 16:29:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1492426 | Horizon Therapeutics Public Ltd Co | HZNP | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1512985 | A. Michael Desjardin | C/O Horizon Therapeutics Plc, Connaught House 1St Fl, 1 Burlington Rd Dublin L2 4 | Evp, Technical Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2020-05-05 | 8,980 | $38.00 | 59,159 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2020-05-06 | 8,980 | $41.19 | 50,179 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2020-05-06 | 8,979 | $42.00 | 41,200 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2020-05-07 | 23,159 | $14.93 | 64,359 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2020-05-07 | 23,159 | $0.00 | 23,159 | $14.93 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 13,654 | 2026-12-14 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 4, 2020.
- 25% of the shares subject to the option vested and became exercisable on the first anniversary of the date of grant (December 15, 2016), and the remaining shares vest in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
